With schools nationwide back in session, millions of children across the United States will clamber up the jungle gyms and hang from the monkey bars that have been a fixture of playgrounds since they were invented in the ...
Sep 9, 2024
0
0
Data from a Phase 3 study has revealed that ivonescimab demonstrates a statistically significant and clinically meaningful improvement in progression-free survival compared to pembrolizumab for patients with PD-L1-positive ...
Sep 8, 2024
0
0
New data presented today demonstrate that TROP2 expression as measured by quantitative continuous scoring (QCS), a computational pathology approach, is a promising predictor of clinical outcomes in patients with advanced ...
Sep 8, 2024
0
0
The antibody–drug conjugate ifinatamab deruxtecan (I-DXd) has shown clinically meaningful responses in pretreated patients with extensive-stage small cell lung cancer (ES-SCLC), according to an interim analysis of the Phase ...
Sep 7, 2024
0
0
For patients with metastatic or surgically unresectable leiomyosarcoma, combination therapy with doxorubicin and trabectedin is associated with improved overall and progression-free survival compared with doxorubicin alone, ...
Sep 6, 2024
0
0
Recent research highlights the importance of targeted therapies for treating advanced colorectal cancer (CRC) with rare genetic variants. These mutations, often linked to poor prognosis and limited response to conventional ...
Aug 23, 2024
0
1
Belzutifan, a hypoxia-inducible factor 2α (HIF-2α) inhibitor, improves progression-free survival and objective responses over everolimus among patients with advanced clear-cell renal cell carcinoma, according to a study ...
Aug 23, 2024
0
0
Eating the seaweed Ecklonia cava may be able to slow down or prevent Parkinson's disease, according to a 2024 study.
Aug 23, 2024
0
3
Hodgkin's lymphoma (HL), impacting the lymph nodes and lymphatic system, has experienced a gradual increase in survival rates thanks to contemporary chemotherapy. However, challenges persist for patients who exhibit resistance ...
Aug 13, 2024
0
0
Patients with a common heart arrhythmia called atrial fibrillation could benefit from future treatments that target inefficiencies in heart cell metabolism, a new paper has found.
Aug 12, 2024
0
0
